BLC
QGEN icon

Brown, Lisle/Cummings’s Qiagen QGEN Stock Holding History

Brown, Lisle/Cummings’s Portfolio QGEN Stock Details QGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,886
Closed -$83.4K – 621
2024
Q1 		$83.4K Hold
1,886
– – 0.03% 253
2023
Q4 		$86.9K Hold
1,886
– – 0.03% 247
2023
Q3 		$81K Hold
1,886
– – 0.04% 238
2023
Q2 		$90.1K Hold
1,886
– – 0.04% 237
2023
Q1 		$91.9K Hold
1,886
– – 0.05% 220
2022
Q4 		$99.7K Hold
1,886
– – 0.05% 208
2022
Q3 		$82.6K Hold
1,886
– – 0.05% 212
2022
Q2 		$94.4K Hold
1,886
– – 0.05% 206
2022
Q1 		$98K Hold
1,886
– – 0.05% 211
2021
Q4 		$111K Buy
+1,886
New +$108K 0.06% 204

Other funds holding QGEN

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Brown, Lisle/Cummings's QGEN Position: Q2 2024 in Review

Brown, Lisle/Cummings sold out of Qiagen (QGEN) in Q2 2024, closing a stake of 1,886 shares — an estimated $83.4K sold.

Brown, Lisle/Cummings first reported a position in QGEN in Q4 2021 and held it in 10 quarters. The position peaked at $111K in Q4 2021. 304 funds tracked by Wall St. Rank hold QGEN as of Q2 2024.

  • Brown, Lisle/Cummings reported no remaining Qiagen position as of Q2 2024 after selling out during the quarter.
  • Brown, Lisle/Cummings sold 1,886 Qiagen shares in Q2 2024, an estimated $83.4K.
  • Brown, Lisle/Cummings first reported a position in Qiagen in Q4 2021 and held it in 10 quarters.
  • Brown, Lisle/Cummings's Qiagen position peaked at $111K in Q4 2021.
  • 304 funds tracked by Wall St. Rank held Qiagen as of Q2 2024.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2024, filed 17 Jul 2024.